Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (34)
Boya Zhang, William Benton Swanson, Margaret Durdan, Heather N Livingston, Michaela Dodd, Sachith M Vidanapathirana, Alec Desai, Lindsey Douglas, Yuji Mishina, Megan Weivoda & Colin F Greineder. (2024) Affinity targeting of therapeutic proteins to the bone surface—local delivery of sclerostin–neutralizing antibody enhances efficacy. Journal of Bone and Mineral Research 39:6, pages 717-728.
Crossref
Crossref
Yixian Wang, Chenhang Wang, Meng Xia, Zeru Tian, Joseph Zhou, Julian Meyer Berger, Xiang H.-F. Zhang & Han Xiao. (2024) Engineering small-molecule and protein drugs for targeting bone tumors. Molecular Therapy 32:5, pages 1219-1237.
Crossref
Crossref
Brian L. Foster, Emily Y. Chu & Philippe P. Hujoel. 2024. Feldman and Pike' s Vitamin D. Feldman and Pike' s Vitamin D
453
484
.
Jair Antonio Tenorio Castaño. 2024. Tales of Discovery. Tales of Discovery
181
190
.
Morgan C. Marsh & Shawn C. Owen. (2023) Therapeutic Fusion Proteins. The AAPS Journal 26:1.
Crossref
Crossref
Hiroshi Kitoh, Hiroshi Kaneko, Akiko Kitamura & Kenta Sawamura. (2023) Femoral lengthening with enzyme replacement therapy in an adolescent patient with prenatal benign hypophosphatasia: A case report. Journal of Orthopaedic Science 28:6, pages 1487-1491.
Crossref
Crossref
G. Smart, E. D. Jensen, B. F. Poirier & S. Sethi. (2023) The impact of enzyme replacement therapy on the oral health manifestations of hypophosphatasia among children: a scoping review. European Archives of Paediatric Dentistry 24:4, pages 429-440.
Crossref
Crossref
N Jaswanthi, R Sindhu, P Nimmy, D Prabu, M RajMohan, VV Bharathwaj, Dinesh Dhamodhar & S Sathiyapriya. (2023) Effect of Asfotase Alfa in the Treatment of Hypophosphatasia- A Systematic Review. Journal of Pharmacy and Bioallied Sciences 15:Suppl 1, pages S101-S104.
Crossref
Crossref
Jan Rosa. (2023) Osteomalacia. Vnitřní lékařství 69:4, pages 254-260.
Crossref
Crossref
Flavia Amadeu de Oliveira, Fatma F. Mohamed, Yuka Kinoshita, Sonoko Narisawa, Colin Farquharson, Koichi Miyake, Brian L Foster & Jose Luis Millan. (2022)
Gene Therapy Using Recombinant
AAV
Type 8 Vector Encoding
TNAP‐D
10
Improves the Skeletal Phenotypes in Murine Models of Osteomalacia
. JBMR Plus 7:1.
Crossref
Crossref
Eva Maria Wölfel, Simon von Kroge, Levi Matthies, Till Koehne, Karin Petz, Thomas Beikler, Carmen Ulrike Schmid-Herrmann, Bärbel Kahl-Nieke, Konstantinos Tsiakas, René Santer, Nicole Maria Muschol, Jochen Herrmann, Björn Busse, Michael Amling, Tim Rolvien, Nico Maximilian Jandl & Florian Barvencik. (2022) Effects of Infantile Hypophosphatasia on Human Dental Tissue. Calcified Tissue International 112:3, pages 308-319.
Crossref
Crossref
Rena Okawa & Kazuhiko Nakano. (2022) Dental manifestation and management of hypophosphatasia. Japanese Dental Science Review 58, pages 208-216.
Crossref
Crossref
Nipith Charoenngam, Aryan Nasr, Arash Shirvani & Michael F. Holick. (2022) Hereditary Metabolic Bone Diseases: A Review of Pathogenesis, Diagnosis and Management. Genes 13:10, pages 1880.
Crossref
Crossref
Kathryn M. Thrailkill, Evangelia Kalaitzoglou & John L. Fowlkes. (2022) Emerging therapies for the treatment of rare pediatric bone disorders. Frontiers in Pediatrics 10.
Crossref
Crossref
Juan Wu, Wai Keung Leung & Weibin Sun. 2022. Periodontology - Fundamentals and Clinical Features. Periodontology - Fundamentals and Clinical Features.
Fatma F. Mohamed, Michael B. Chavez, Flavia Amadeu de Oliveira, Sonoko Narisawa, Colin Farquharson, José Luis Millán & Brian L. Foster. (2022) Perspective on Dentoalveolar Manifestations Resulting From PHOSPHO1 Loss-of-Function: A Form of Pseudohypophosphatasia?. Frontiers in Dental Medicine 3.
Crossref
Crossref
Marialaura Marchetti, Serena Faggiano & Andrea Mozzarelli. (2022) Enzyme Replacement Therapy for Genetic Disorders Associated with Enzyme Deficiency. Current Medicinal Chemistry 29:3, pages 489-525.
Crossref
Crossref
Symeon Tournis, Maria Yavropoulou, Stergios Polyzos & Artemis Doulgeraki. (2021) Hypophosphatasia. Journal of Clinical Medicine 10:23, pages 5676.
Crossref
Crossref
Robert J. Schroth, Catherine Long, Victor H.K. Lee, Hamideh Alai-Towfigh & Cheryl Rockman-Greenberg. (2021) Dental outcomes for children receiving asfotase alfa for hypophosphatasia. Bone 152, pages 116089.
Crossref
Crossref
Ataf Sabir & Melita Irving. (2021) Clinical trials in skeletal dysplasia: a paradigm for treating rare diseases. British Medical Bulletin 139:1, pages 16-35.
Crossref
Crossref
Tae Matsumoto, Koichi Miyake, Noriko Miyake, Osamu Iijima, Kumi Adachi, Sonoko Narisawa, José Luis Millán, Hideo Orimo & Takashi Shimada. (2021) Treatment with bone maturation and average lifespan of HPP model mice by AAV8-mediated neonatal gene therapy via single muscle injection. Molecular Therapy - Methods & Clinical Development 22, pages 330-337.
Crossref
Crossref
Stephanie Graser, Daniel Liedtke & Franz Jakob. (2021) TNAP as a New Player in Chronic Inflammatory Conditions and Metabolism. International Journal of Molecular Sciences 22:2, pages 919.
Crossref
Crossref
Tess Chamakkala & Thomas Gallagher. (2021) Hypophosphatasia: A missed diagnosis. International Journal of Academic Medicine 7:1, pages 62.
Crossref
Crossref
Allen W. Root & Michael A. Levine. 2021. Sperling Pediatric Endocrinology. Sperling Pediatric Endocrinology
705
813
.
Fatma F. Mohamed, Michael B. Chavez, Shannon Huggins, Joshua Bertels, Alyssa Falck, Larry J. Suva, Brian L. Foster & Dana Gaddy. (2020) Dentoalveolar Defects of Hypophosphatasia are Recapitulated in a Sheep Knock-In Model. Journal of Bone and Mineral Research 37:10, pages 2005-2017.
Crossref
Crossref
Nipith Charoenngam, Muhammet B. Cevik & Michael F. Holick. (2020) Diagnosis and management of pediatric metabolic bone diseases associated with skeletal fragility. Current Opinion in Pediatrics 32:4, pages 560-573.
Crossref
Crossref
E.Y. Chu, T.D. Vo, M.B. Chavez, A. Nagasaki, E.L. Mertz, F.H. Nociti, S.F. Aitken, D. Kavanagh, K. Zimmerman, X. Li, P.R. Stabach, D.T. Braddock, J.L. Millán, B.L. Foster & M.J. Somerman. (2020) Genetic and pharmacologic modulation of cementogenesis via pyrophosphate regulators. Bone 136, pages 115329.
Crossref
Crossref
Sebastian Simon & Heinrich Resch. (2020) Treatment of hypophosphatasiaBehandlung der Hypophosphatasie. Wiener Medizinische Wochenschrift 170:5-6, pages 112-115.
Crossref
Crossref
Livera Grace & Raymond Surya. (2020) Perinatal severe hypophosphatasia: a case report. Case Reports in Perinatal Medicine 9:1.
Crossref
Crossref
Mizuki Takagi, Shunsuke Kato, Taichiro Muto, Yoshimi Sano, Tomoyuki Akiyama, Junko Takagi, Akihisa Okumura & Hideyuki Iwayama. (2020) Odontohypophosphatasia treated with asfotase alfa enzyme replacement therapy in a toddler: a case report. Clinical Pediatric Endocrinology 29:3, pages 115-118.
Crossref
Crossref
Stephen E. Harris, Audrey Rakian, Brian L. Foster, Yong-Hee Patricia Chun & Rubie Rakian. 2020. Principles of Bone Biology. Principles of Bone Biology
1061
1082
.
Ataf Hussain Sabir & Trevor Cole. (2019) The evolving therapeutic landscape of genetic skeletal disorders. Orphanet Journal of Rare Diseases 14:1.
Crossref
Crossref
Luciane Martins, Amanda Bandeira de Almeida, Elis Janaína Lira dos Santos, Brian L. Foster, Renato Assis Machado, Kamila Rosamilia Kantovitz, Ricardo D. Coletta & Francisco H. NocitiJrJr. (2019) A novel combination of biallelic ALPL mutations associated with adult hypophosphatasia: A phenotype-genotype association and computational analysis study. Bone 125, pages 128-139.
Crossref
Crossref
Daniel Azpiazu, Sergio Gonzalo & Ricardo Villa-Bellosta. (2019) Tissue Non-Specific Alkaline Phosphatase and Vascular Calcification: A Potential Therapeutic Target. Current Cardiology Reviews 15:2, pages 91-95.
Crossref
Crossref